Accrufer® New Drug Submission accepted by Health Canada
Trader’s Cafe with Zak Mir: TGR, TILS, COPL, SCE, STX, IMC, PNPL, RMS & TERN via Vox Markets
Since coming to market in December, specialist graphite producer and graphene and advanced materials developer Tirupati Graphite (TGR) has hit the mark with its newsflow on a consistent basis.
Shield Therapeutics (STX.L) US launch of Accrufer® confirmed for July 1, 2021
London, UK, June 24, 2021: Shield Therapeutics plc (LSE: STX), a commercial stage, pharmaceutical company with a focus on addressing iron deficiency with its lead product Feraccru®/Accrufer® (ferric maltol), confirms
Shield Therapeutics (STX.L) USA Deal
Shield confirms it remains on track to launch Accrufer® in the US by end of June 2021
Share Talk Bulletin Board Heroes, Monday 29th March 2021
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview in this video charting update.
Share Talk Bulletin Board Heroes, Friday 19th February 2021
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview in this video charting update.
Share Talk Bulletin Board Heroes, Thursday 17th September 2020
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview of the fundamentals in this video charting update.
Share Talk Bulletin Board Heroes, Thursday 30th April 2020
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview of the fundamentals in this charting update. Exclusive to Share Talk, here
Share Talk Bulletin Board Heroes, Tuesday 24th March 2020
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview of the fundamentals in this charting update. Exclusive to Share Talk, here